MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 6101-6110 Newer>
The Motley Fool
December 24, 2009
Brian Orelli
Another Reason to Worry About Pfizer The FDA fails to approve Lyrica for treating anxiety. mark for My Articles 733 similar articles
The Motley Fool
December 23, 2009
Brian Orelli
Cancer Isn't Merck's Biggest Problem There's still hope for Merck's Vytorin, but investors will have to wait. mark for My Articles 411 similar articles
The Motley Fool
December 23, 2009
Brian Orelli
2009 Cheers and Jeers for Pharma Unfortunately, it was more of the latter. mark for My Articles 1174 similar articles
The Motley Fool
December 22, 2009
Brian Orelli
This Acquisition Is Icy Hot Expensive price, but Chattem may still be a good buy for sanofi-aventis. mark for My Articles 332 similar articles
The Motley Fool
December 22, 2009
Brian Orelli
Pfizer Swings for the Fences A long shot, but at least it's cheap. Pfizer seems to have taken a particular liking to stem cells, having established a unit to study them last year mark for My Articles 492 similar articles
The Motley Fool
December 22, 2009
Brian Orelli
Some Incyte Into Why These Drugs Rock Eli Lilly jumps on the oral-drug-for-rheumatoid-arthritis bandwagon. mark for My Articles 526 similar articles
The Motley Fool
December 22, 2009
Brian Orelli
2009 Biotech Cheers and Jeers Lessons from biotech's 2009 surprises. Will 2010 be just as exciting? Considering that it's biotech, I'd have to say "yes." mark for My Articles 595 similar articles
The Motley Fool
December 18, 2009
Brian Orelli
Swine Flu Just Isn't Bringing Home the Bacon Looks like that one-time boost from sales of swine flu vaccine may not add much to the bottom lines of vaccine makers like GlaxoSmithKline, AstraZeneca, sanofi-aventis, and Novartis. mark for My Articles 292 similar articles
The Motley Fool
December 18, 2009
Brian Orelli
2009: The Year Pharma Learned to Love Itself While anything is possible, don't expect too much more consolidation of major drugmakers in 2010 and beyond. mark for My Articles 1486 similar articles
The Motley Fool
December 18, 2009
Brian Orelli
Buy a Company, Get the Plant for Free Earlier this year, Merck company bought a pipeline of follow-on biologics (and a manufacturing plant to make them in) from Insmed. Now it's back for more with an acquisition of Avecia Biologics. mark for My Articles 266 similar articles
<Older 6101-6110 Newer>    Return to current articles.